
Reset all filters
01 7Otezla
02 3Otezla
Main Therapeutic Indication : Dermatology
Currency : USD
2020 Revenue in Millions : 2,195
2019 Revenue in Millions : 178
Growth (%) : 1,133
Main Therapeutic Indication : Dermatology
Currency : USD
2021 Revenue in Millions : 2,249
2020 Revenue in Millions : 2,195
Growth (%) : 2
Main Therapeutic Indication : Dermatology
Currency : USD
2022 Revenue in Millions : 2,288
2021 Revenue in Millions : 2,249
Growth (%) : 2
Main Therapeutic Indication : Dermatology
Currency : USD
2023 Revenue in Millions : 2,188
2022 Revenue in Millions : 2,288
Growth (%) : -4
Main Therapeutic Indication : Dermatology
Currency : USD
2019 Revenue in Millions : 178
2018 Revenue in Millions : 0
Growth (%) : N/A
Main Therapeutic Indication : Skin Disorder
Currency : USD
2015 Revenue in Millions : 70
2014 Revenue in Millions : 472
Growth (%) : 574%
Main Therapeutic Indication : Dermatology
Currency : USD
2017 Revenue in Millions : 1,279
2016 Revenue in Millions : 1,017
Growth (%) : 26
Main Therapeutic Indication : Dermatology
Currency : USD
2016 Revenue in Millions : 1,017
2015 Revenue in Millions : 472
Growth (%) : 115
Main Therapeutic Indication : Dermatology
Currency : USD
2018 Revenue in Millions : 1,608
2017 Revenue in Millions : 1,279
Growth (%) : 26%
Main Therapeutic Indication : Dermatology
Currency : USD
2019 Revenue in Millions : 1,429
2018 Revenue in Millions : 1,608
Growth (%) : -11